GATALYST Trademark

Trademark Overview

On Thursday, April 22, 2021, a trademark application was filed for GATALYST with the United States Patent and Trademark Office. The USPTO has given the GATALYST trademark a serial number of 90664993. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, September 2, 2025. This trademark is owned by Stellate Biotherapeutics, Inc.. The GATALYST trademark is filed in the Pharmaceutical Products category with the following description:

Gene therapy products, namely, custom donor genetic material in the nature of human cells for use in genome modification; Biological preparations for use in the genetic treatment of pathological medical conditions, namely, cancer, neurological diseases, autoimmune diseases, and genetic disorders
gatalyst

General Information

Serial Number90664993
Word MarkGATALYST
Filing DateThursday, April 22, 2021
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, September 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2022

Trademark Statements

Goods and ServicesGene therapy products, namely, custom donor genetic material in the nature of human cells for use in genome modification; Biological preparations for use in the genetic treatment of pathological medical conditions, namely, cancer, neurological diseases, autoimmune diseases, and genetic disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 29, 2021
Primary Code005
First Use Anywhere DateMonday, September 30, 2024
First Use In Commerce DateMonday, September 30, 2024

Trademark Owner History

Party NameFULL CIRCLES THERAPEUTICS, INC.
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
Party NameFULL CIRCLES THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02138
Party NameStellate Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameStellate Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Friday, December 17, 2021NON-FINAL ACTION WRITTEN
Monday, April 26, 2021NEW APPLICATION ENTERED
Thursday, July 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Friday, December 17, 2021NON-FINAL ACTION E-MAILED
Friday, December 17, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 11, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, April 21, 2022ASSIGNED TO PETITION STAFF
Friday, April 22, 2022POST PUBLICATION AMENDMENT - ENTERED
Tuesday, May 17, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, November 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 16, 2022SOU EXTENSION 1 FILED
Wednesday, November 16, 2022SOU EXTENSION 1 GRANTED
Friday, November 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2023SOU EXTENSION 2 FILED
Tuesday, May 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023SOU EXTENSION 3 FILED
Tuesday, November 7, 2023SOU EXTENSION 3 GRANTED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, November 15, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 16, 2024SOU EXTENSION 4 FILED
Thursday, May 16, 2024SOU EXTENSION 4 GRANTED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2024SOU EXTENSION 5 FILED
Sunday, January 26, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 29, 2025SOU EXTENSION 5 GRANTED
Thursday, January 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 21, 2025USE AMENDMENT FILED
Friday, February 21, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, February 22, 2025STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 27, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 27, 2025SU - NON-FINAL ACTION - WRITTEN
Thursday, February 27, 2025NON-FINAL ACTION E-MAILED
Friday, May 23, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, August 25, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 2, 2025ASSIGNED TO LIE
Tuesday, September 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 23, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Related Keywords

gatalyst genetic namely diseases medical pathological treatment conditions preparations biological autoimmune